Journey Medical Corporation Quarterly report [Sections 13 or 15(d)]

INTEREST EXPENSE AND FINANCING FEES

6 Months Ended

Jun. 30, 2026

NOTE 12. INTEREST EXPENSE AND FINANCING FEES

Interest expense and financing fees for the three and six-month periods ended June 30, 2026 and 2025 consisted of the following:


		Three-Month Periods Ended				Six-Month Periods Ended
		June 30,				June 30,
($’s in thousands)		2026		2025		2026		2025
Cash interest expense		$	807	$	813	$	1,603	$	1,603
Amortization of debt discount			99		124		195		225
Total interest expense and financing fees		$	906	$	937	$	1,798	$	1,828